ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud ...
Zacks Investment Research on MSN
Here is what to know beyond why Abbott Laboratories (ABT) is a trending stock
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ ...
This article examines whether Abbott Laboratories, at around US$104 a share, is starting to look interesting or still pricing ...
View Abbott Laboratories ABT stock quote prices, financial information, real-time forecasts, and company news from CNN.
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.
This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...
Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...
Check out the latest Abbott Laboratories (ABT) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure ...
Shares of Abbott Laboratories ABT slid 2.03% to $101.88 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results